Patents for A61K 49 - Preparations for testing in vivo (35,376)
04/2013
04/17/2013CN102688506B Gastrointestinal contrast agent containing Chinese herbal extracts
04/17/2013CN102600486B Medical ultrasonic coupling agent and preparation method thereof
04/17/2013CN101948694B Rare earth upconversion nano crystal/silver difunctional composite nano material, preparation method thereof and application thereof in cancer detection and treatment
04/17/2013CN101374555B Methods for measuring the metabolism of neurally derived biomolecules in vivo
04/16/2013US8422755 System and method for synchronizing image sequences captured in-vivo for automatic comparison
04/16/2013US8420603 SPARC and methods of use thereof
04/16/2013US8420056 Abuse-proofed dosage form
04/16/2013US8420055 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
04/16/2013US8420054 Noninvasive method for measuring histamine from skin as an objective measurement of itch
04/16/2013US8420053 Gastrin releasing peptide compounds
04/16/2013US8420051 Muteins of hNGAL and related proteins with affinity for a given target
04/11/2013WO2013051732A1 Liposome composite body
04/11/2013WO2013021300A3 Imaging using sets of carbon nanotubes
04/11/2013WO2013019151A3 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof
04/11/2013WO2013010176A3 Pharmacophores for amyloid fibers involved in alzheimer's disease
04/11/2013US20130091591 Artery- and vein-specific proteins and uses therefor
04/11/2013US20130089505 Single vial formulation for medical grade cyanoacrylate
04/11/2013US20130089495 Method for screening size of carrier
04/11/2013DE102011054396A1 Use of substituted 3,3-dimethyl-2,3-dihydro-1H-indole derivatives as a marker and/or a contrast agent in an imaging process and/or in biomedical analysis
04/11/2013CA2841867A1 Dye conjugated peptides for fluorescent imaging
04/10/2013EP2579027A1 Fluorescent probe for imaging lymph nodes
04/10/2013EP2578684A1 Antagonists of ligands and uses thereof
04/10/2013EP2578237A1 Compositions and methods for enhancing contrast in imaging
04/10/2013EP2576699A1 Naphthocyanines for use as contrast agents
04/10/2013EP2575896A2 Magnetically responsive membrane structures
04/10/2013EP2575772A2 Magnetic nanoparticles
04/10/2013CN103038629A Fluorescent probe for imaging lymph nodes
04/10/2013CN103038289A Naphthocyanines for use as contrast agents
04/10/2013CN103030689A CART polypeptide compound, and preparation method and application of compound
04/10/2013CN103027897A Method for preparing monodispersity hydrophobic drug nanoparticles by template method
04/10/2013CN102552939B Targeting PLGA (poly(lactic-co-glycolic acid)) fluorescence probe coated with methylene blue and the preparation method thereof
04/10/2013CN102397565B Target-dextran-USPIO (Ultra-small Superparamagnetic Iron Oxide) compound particle and preparation method and application thereof
04/09/2013US8415304 Sparc and methods of use thereof
04/09/2013US8414892 Uses of monoclonal antibody 8H9
04/09/2013US8414865 Use of Mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
04/09/2013US8414864 Gastrin releasing peptide compounds
04/09/2013CA2677041C Multimeric conjugate
04/09/2013CA2224176C Gene transfer for treating a connective tissue of a mammalian host
04/04/2013WO2013049405A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
04/04/2013WO2013049112A1 Detection of biomarkers using magnetic resonance
04/04/2013WO2013048022A2 Α-type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an α-type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same
04/04/2013WO2013046076A1 Automated ultrasound mediated delivery.
04/04/2013WO2013045662A1 Peptide margin imaging agents
04/04/2013WO2013045650A2 Infusion imaging method
04/04/2013WO2013045504A1 Perfluorinated nanoemulsions, method for preparing same, and use thereof as a contrast agent
04/04/2013WO2013045333A1 Nanoemulsions and use thereof as contrast agents
04/04/2013WO2013013067A3 Microbubble compositions, method of making same, and method using same
04/04/2013WO2012177039A3 Mri contrast agent for lymphography based on iron oxide nanoparticles and method for imaging lymph node using the same
04/04/2013US20130085384 Medical-surgical devices
04/04/2013US20130084248 Stabilized, biocompatible gold nanoparticles
04/04/2013US20130084247 Compositions and methods to prevent cancer with cupredoxins
04/04/2013US20130084246 Method and system for quantitative renal assessment
04/04/2013DE102009060317B4 Kontrastmittel zur Verwendung in einem bildgebenden Verfahren zur Diagnose einer metastasierenden Tumorerkrankung und Verfahren zur Abbildung eines metastasierenden Tumorgewebes Contrast agents for use in an imaging method of diagnosing a metastatic tumor and method for imaging a metastatic tumor tissue
04/04/2013CA2850198A1 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
04/03/2013EP2574671A1 Antagonists of ligands and uses thereof
04/03/2013CN103025758A IL-1 binding proteins
04/03/2013CN103025357A Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
04/03/2013CN103025317A Nalbuphine-based formulations and uses thereof
04/03/2013CN103025314A Magnetic nanoparticles
04/03/2013CN103012562A Dual-targeting D-configuration polypeptides and drug delivery system thereof
04/03/2013CN103012561A Small peptide for tumor targeted diagnosis
04/03/2013CN103012401A Preparation method and application of anthraquinone polypyridine ligand and ruthenium-anthraquinone complex
04/03/2013CN103007305A Preparation method of transparent bactericidal medical ultrasonic coupling agent
04/03/2013CN103007304A CT/MRI (computerized tomography/magnatic resonance imaging) double-function Mn3O4 nanoparticles and preparation method thereof
04/03/2013CN103007303A Core-shell type tri-modal nano contrast agent as well as preparation method and application thereof
04/03/2013CN103007302A Gd2O3-TiO2 composite nanoparticle as well as preparation method and application thereof
04/03/2013CN103007301A Ferroferric oxide nano particles with CT/MRI (Computed Tomography/Magnetic Resonance Imaging) double functions as well as preparation method and application thereof
04/03/2013CN103007300A Macromolecule developing agent with passive-initiative dual tumor targeted function and synthesis thereof
04/03/2013CN103007299A Parkinson's disease animal model platform and application of platform in medicine screening
04/03/2013CN103007298A Medical lubricant for sterilizing and balancing potential of hydrogen and preparation process of medical lubricant
04/03/2013CN103007297A Preparation method of lubricating agent for gastroscope
04/03/2013CN103007296A Mould for intervention of liraglutide in GK rat and application thereof in intervention treatment diabetes B medicine
04/03/2013CN103007295A Medical imaging material, and preparation method and application thereof
04/03/2013CN103007285A Preparation method for folic acid-decorated and rare earth-modified carbon nano tube
04/03/2013CN103006538A Ultrasonic microbubbles for treating arthritis and use thereof
04/03/2013CN102389399B Preparation method of drug-loaded microspheres capable of enhancing anticancer effect of paclitaxel by ultraviolet radiation and application thereof
04/03/2013CN101076356B Electroporation of mycobacterium and overexpression of antigens in mycobacteria
04/03/2013CN101027099B Diagnostic marker for cancer
04/02/2013US8410251 Antibody against calcified globule and use of the same
04/02/2013US8410172 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
03/2013
03/28/2013WO2013043902A1 Targeted nanoparticles joined to reporter molecules through multiple mechanisms
03/28/2013WO2013041810A1 Stable, low-toxicity, sterilizable composition for ophthalmic dying
03/28/2013WO2013041623A1 Novel manganese comprising nanostructures
03/28/2013WO2013041250A1 Cross-linked poly-e-lysine non-particulate support
03/28/2013WO2012123916A3 Activatable fluorogenic compounds and uses thereof as near infrared probes
03/28/2013WO2012041292A3 Compounds for diagnosing neurodegenerative diseases at the retina
03/28/2013US20130079767 Embolization
03/28/2013US20130078189 Formation and uses of europium complexes
03/28/2013US20130078188 Activatable cell penetrating peptides with quenched fluorophores
03/28/2013US20130078187 Method for Selecting Bacteria with Anti-Oxidant Action
03/28/2013CA2847804A1 Novel manganese comprising nanostructures
03/28/2013CA2833589A1 Cross-linked poly-e-lysine non-particulate support
03/27/2013EP2572736A1 Nanostructures comprising manganese
03/27/2013EP2572735A1 Imaging diagnostics by combining contrast agents
03/27/2013EP2571532A2 Il-1 binding proteins
03/27/2013EP2571531A2 Stabilized fibronectin domain compositions, methods and uses
03/27/2013EP2571529A2 Functional, cross-linked nanostructures for tandem optical imaging and therapy
03/27/2013CN103002924A Compositions, methods and systems for the synthesis and use of imaging agents
03/27/2013CN103002923A Stabilized fibronectin domain compositions, methods and uses
03/27/2013CN103002921A Functional, cross-linked nanostructures for tandem optical imaging and therapy
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 354